

Biodexa Pharmaceuticals shares are trading sharply higher Thursday afternoon after the company said it partnered with Syngene International.
You can purchase shares of Biodexa Pharmaceuticals (NASDAQ:BDRX) through any online brokerage.
Other companies in Biodexa Pharmaceuticals’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Moderna Inc (NASDAQ:MRNA).
Biodexa Pharmaceuticals has a consensus price target of $80000.00.
The stock price for Biodexa Pharmaceuticals (NASDAQ: BDRX) is $2.36 last updated November 9, 2026 at 3:03 AM EST.
There are no upcoming dividends for Biodexa Pharmaceuticals.
Biodexa Pharmaceuticals does not have any upcoming earnings scheduled.
There is no upcoming split for Biodexa Pharmaceuticals.
Biodexa Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Biodexa Pharmaceuticals PLC is a clinical-stage biopharmaceutical company focused on developing a pipeline of products to treat diseases that have unmet medical needs. These include familial adenomatous polyposis (FAP), non-muscle invasive bladder...